免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

cobas c513 分析儀,cobas c13 Tina-quant HbA1cDx Gen.3 檢測試劑

K 號:K160571 · 2016-12-19

決定日期2016-12-19
產品代碼PDJ
諮詢委員會CH
決定相當於

器材摘要

cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is the device name listed in this FDA 510(k) record. The listed applicant is Roche Diagnostics Operations (Rdo). It received FDA 510(k) clearance on 2016-12-19 under 510(k) number K160571. The device is classified under product code PDJ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?

cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is a medical device that received FDA 510(k) clearance on 2016-12-19. The listed applicant is Roche Diagnostics Operations (Rdo). The 510(k) number is K160571.

When did cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay receive FDA 510(k) clearance?

cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay received FDA 510(k) clearance on 2016-12-19, under 510(k) number K160571.

Who is the listed applicant for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?

The FDA 510(k) record lists Roche Diagnostics Operations (Rdo) as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?

The FDA product code for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is PDJ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Roche Diagnostics Operations (Rdo) 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 10 項裝置 →

相關器械(代碼:PDJ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑